Navigation Links
ShangPharma Announces Second Quarter 2011 Results
Date:8/22/2011

ures also facilitate management's internal comparisons to the Company's historical performance. The Company computes its non-GAAP financial measures using the same consistent method from quarter to quarter. The Company believes these non-GAAP financial measures are useful to investors in allowing for greater transparency with respect to supplemental information used by management in its financial and operational decision making. A limitation of using non-GAAP financial measures excluding expenses relating to or the effect of share-based compensation is that these expenses and effects have been and will continue to be significant recurring expenses in the Company's business for the foreseeable future. Management compensates for these limitations by providing specific information regarding the GAAP amount excluded from each non-GAAP measure. The accompanying tables have more details on the reconciliation between non-GAAP financial measures and their most comparable GAAP financial measures.

For further information, please contact:ShangPharma CorporationIn Shanghai, China
Lan Xie
VP of Finance and Operations
E-mail: IR@shangpharma.comChristensen

In New York, US
Kimberly Minarovich, +1 917-533-3268
kminarovich@christensenir.comIn Hong Kong
Tip Fleming, +852-9212-0684
tfleming@christensenir.comSHANGPHARMA CORPORATIONUNAUDITED CONSOLIDATED BALANCE SHEET(in thousands of U.S. dollars, except for ordinary share data) 

 

December 31,

June 30,  

 

2010

2011 ASSETSCurrent assets: 

 Cash and cash equivalents

49,160

41,550 

 Restricted cash

688

840 

 Accounts receivable, net

16,908

20,261 

 A
'/>"/>

SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise
2. ShangPharma Announces First Quarter 2011 Results
3. ShangPharma Corp. to Announce Fourth Quarter and Full Year 2010 Financial Results on March 15, 2011
4. Stem Cell Assurance, Inc. Announces Change of Name to BioRestorative Therapies, Inc.
5. Syndax Pharmaceuticals Announces Issuance of EU Patent for Entinostat
6. Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA
7. ACMG Announces New Online Live Learning Center: Will Bring Genetics and Genomics Education to Varied Health Professionals
8. Neurologix Announces Second Quarter 2011 Financial Results
9. Bion Announces New U.S. Patent for Phosphorus Removal
10. ViaCyte Announces Executive Management Changes
11. NeoStem Announces the Receipt of Over $1,700,000 in DOD Funding for its VSEL™ Technology Being Developed to Treat Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... RURO, Inc., Laboratory Information Management System ... the opening of its first international office. Located ... in Shanghai, PRC, RURO Shanghai’s doors are open. ... Mr. Shen Gang, the former Technical Director of ... RURO’s has installed FreezerPro-based solutions in more than ...
(Date:8/1/2014)... 2014 The  PROPEL Center  of the  iBIO ... rate of early-stage life sciences companies in ... 15 grants to help Illinois ...   in Chicago .   AdvaMed ... North America , bringing more than 1,000 ...
(Date:8/1/2014)... BCC Research ( http://www.bccresearch.com ) reveals in its ... MARKETS , that the global market RNA interference (RNAi) ... $38.8 billion by 2018, with a five-year compound annual ... the fastest moving segment of the market, is moving ... RNAi therapeutics has shown tremendous growth and has moved ...
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 ... consumers, are increasingly searching for food alternatives that ... nutritional benefits. The food ingredient market has numerous ... players such as Vital Force Technology (VFT). ... more than 4,000 energetic patterns, all tested to ...
Breaking Biology Technology:RURO Opens Office in Shanghai, China 2iBIO Institute's PROPEL Center Awards Grants for AdvaMed 2014 to Early-Stage Life Sciences Companies 2iBIO Institute's PROPEL Center Awards Grants for AdvaMed 2014 to Early-Stage Life Sciences Companies 3iBIO Institute's PROPEL Center Awards Grants for AdvaMed 2014 to Early-Stage Life Sciences Companies 4Global Market for RNAi Drug Delivery Technologies to Reach $38.8 Billion in 2018; Aptamer Delivery Segment Surging at 58.2% CAGR 2Global Market for RNAi Drug Delivery Technologies to Reach $38.8 Billion in 2018; Aptamer Delivery Segment Surging at 58.2% CAGR 3Functional Ingredient Manufacturer – Vital Force Technology Infuses Raw Materials & Ingredients with Subtle Energy Formula 2
... 18 Derma Sciences, Inc.,(OTC Bulletin Board: DSCI), a ... increased its direct-sales staff significantly, based on a,number of ... The,company, which had only two direct salespersons in the ... to 21 by 2009. The increase is a significant ...
... ACEL ) today announced that it has ... Protein Laboratories LLC (SPL) for the,commercial production of ... currently being evaluated as a treatment for,unresectable malignant ... "SPL has been involved in the production ...
... International Group, Ltd.,(Bloomberg: BIG SP, Company or Biosensors), ... (CE) Mark approval for its,BioMatrix(R) drug-eluting stent system, ... and the countries in Asia and Latin America,that ... system,developed internally by the Company, consists of a ...
Cached Biology Technology:Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008 2Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008 3Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories 2Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories 3Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System 2Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System 3Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System 4
(Date:7/31/2014)... by the National Science Foundation (NSF), counters a ... atmospheric warming, indicating instead that certain Arctic lakes ... the atmosphere. , The study, published this ... on thermokarst lakes, which occur as permafrost thaws ... fresh water, converting what was previously frozen land ...
(Date:7/31/2014)... known that biomass burning burning forests to ... , slash-and-burn agriculture and wildfires figures into ... until the release of a new study by ... Z. Jacobson, the degree of that contribution had ... in a paper published July 30 in the ...
(Date:7/31/2014)... hazard lurks beneath many of the roughly 156,000 ... hazard is corrosion in parts of underground gas ... and contamination of groundwater, a source of drinking ... states have reported many rapidly corroding gas storage ... are generally associated with use of gasoline-ethanol blends ...
Breaking Biology News(10 mins):Certain Arctic lakes store more greenhouse gases than they release 2Stanford professor finds that wildfires and other burns play bigger role in climate change 2Stanford professor finds that wildfires and other burns play bigger role in climate change 3Stanford professor finds that wildfires and other burns play bigger role in climate change 4NIST corrosion lab tests suggest need for underground gas tank retrofits 2
... Chalfie of Columbia University , Nobel Laureate Eric Wieschaus ... Scripps Research Institute, ASCB public information chairman Rex Chisholm ... informal, good-natured, and intimate program that will use a ... targeted to young researchers. Sponsored by ASCB,s PIC, the ...
... landmark collection of papers that together provide a ... and organizations in sub-Saharan Africa addressing neglected health ... creative scientific and business solutions. The first-of-its ... entrepreneurs, institutes and firms in Africa creating innovative, ...
... the first time, scientists have created functioning human intestinal ... In a study posted online Dec. 12 by ... say their findings will open the door to unprecedented ... process is also a significant step toward generating intestinal ...
Cached Biology News:Studies detail triumphs, troubles of African innovators creating products for local health needs 2Studies detail triumphs, troubles of African innovators creating products for local health needs 3Studies detail triumphs, troubles of African innovators creating products for local health needs 4Studies detail triumphs, troubles of African innovators creating products for local health needs 5Studies detail triumphs, troubles of African innovators creating products for local health needs 6Studies detail triumphs, troubles of African innovators creating products for local health needs 7Studies detail triumphs, troubles of African innovators creating products for local health needs 8Studies detail triumphs, troubles of African innovators creating products for local health needs 9Studies detail triumphs, troubles of African innovators creating products for local health needs 10Studies detail triumphs, troubles of African innovators creating products for local health needs 11Studies detail triumphs, troubles of African innovators creating products for local health needs 12Studies detail triumphs, troubles of African innovators creating products for local health needs 13Studies detail triumphs, troubles of African innovators creating products for local health needs 14Studies detail triumphs, troubles of African innovators creating products for local health needs 15Studies detail triumphs, troubles of African innovators creating products for local health needs 16Studies detail triumphs, troubles of African innovators creating products for local health needs 17Studies detail triumphs, troubles of African innovators creating products for local health needs 18Studies detail triumphs, troubles of African innovators creating products for local health needs 19Stem cells turned into complex, functioning intestinal tissue in lab 2Stem cells turned into complex, functioning intestinal tissue in lab 3
AedestaTM Animal Organ/Tissue Perfusion Soln....
RAT ANTI MOUSE JAM-2 Immunogen: Recombinant soluble JAM-2...
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds...
... Spots, Oligo Spots and complementary RNA Spikes ... experiments. Use for glass array printing and ... reverse transcription, cDNA labeling, hybridization stringency and ... Control PCR Spots and Oligo Spots, and ...
Biology Products: